Smith Graham & Co Investment Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.91M Sell
12,793
-1,312
-9% -$276K 0.34% 132
2023
Q3
$2.84M Sell
14,105
-2,449
-15% -$517K 0.35% 130
2023
Q2
$3.43M Sell
16,554
-137
-0.8% -$26.6K 0.42% 117
2023
Q1
$3.29M Sell
16,691
-392
-2% -$80.7K 0.4% 119
2022
Q4
$3.46M Sell
17,083
-420
-2% -$82.1K 0.42% 114
2022
Q3
$3.08M Sell
17,503
-1,024
-6% -$210K 0.41% 118
2022
Q2
$3.73M Sell
18,527
-476
-3% -$101K 0.46% 110
2022
Q1
$4.3M Buy
19,003
+657
+4% +$155K 0.45% 105
2021
Q4
$4.95M Sell
18,346
-279
-1% -$69.1K 0.49% 95
2021
Q3
$4.5M Sell
18,625
-2,038
-10% -$514K 0.45% 98
2021
Q2
$4.9M Sell
20,663
-3,386
-14% -$771K 0.43% 101
2021
Q1
$5.27M Sell
24,049
-3,165
-12% -$635K 0.43% 104
2020
Q4
$4.76M Sell
27,214
-2,537
-9% -$438K 0.44% 107
2020
Q3
$4.81M Sell
29,751
-1,245
-4% -$197K 0.55% 80
2020
Q2
$4.42M Buy
30,996
+101
+0.3% +$14K 0.54% 87
2020
Q1
$3.35M Buy
30,895
+224
+0.7% +$32.3K 0.52% 90
2019
Q4
$4.46M Sell
30,671
-815
-3% -$118K 0.43% 123
2019
Q3
$4.54M Buy
31,486
+93
+0.3% +$13.6K 0.48% 119
2019
Q2
$4.66M Sell
31,393
-1,315
-4% -$183K 0.5% 117
2019
Q1
$4.3M Buy
32,708
+349
+1% +$43K 0.47% 126
2018
Q4
$3.51M Sell
32,359
-140
-0.4% -$18.8K 0.43% 128
2018
Q3
$4.85M Sell
32,499
-1,304
-4% -$198K 0.46% 122
2018
Q2
$5.21M Sell
33,803
-675
-2% -$102K 0.49% 119
2018
Q1
$4.79M Sell
34,478
-314
-0.9% -$46.1K 0.46% 122
2017
Q4
$4.77M Buy
34,792
+22,128
+175% +$2.92M 0.45% 124
2017
Q3
$1.64M Buy
+12,664
New +$1.69M 0.17% 132

Other funds holding LH

Smith Graham & Co Investment Advisors's LH Position: Q4 2023 in Review

Smith Graham & Co Investment Advisors reduced its Labcorp (LH) stake by 9.3% in Q4 2023, selling an estimated $276K and leaving 12,793 shares worth $2.91M. The position accounts for 0.34% of the portfolio, ranked #132.

Smith Graham & Co Investment Advisors first reported a position in LH in Q3 2017 and has held it in 26 quarters since. The position peaked at $5.27M in Q1 2021. 956 funds tracked by Wall St. Rank hold LH as of Q4 2023.

  • Smith Graham & Co Investment Advisors held 12,793 shares of Labcorp worth $2.91M as of Q4 2023.
  • Smith Graham & Co Investment Advisors sold 1,312 Labcorp shares in Q4 2023, an estimated $276K.
  • Labcorp made up 0.34% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #132 holding.
  • Smith Graham & Co Investment Advisors first reported a position in Labcorp in Q3 2017 and has held it in 26 quarters since.
  • Smith Graham & Co Investment Advisors's Labcorp position peaked at $5.27M in Q1 2021.
  • 956 funds tracked by Wall St. Rank held Labcorp as of Q4 2023.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.